|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.0208701
|
|
|
CF
|
[NCBI]
|
0.00129269
|
|
|
polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive
|
[NCBI]
|
0.000932897
|
|
|
mucus inspissation of respiratory tract
|
[NCBI]
|
0.000932897
|
|
|
respiratory underresponsiveness to hypoxia and hypercapnia
|
[NCBI]
|
0.000516065
|
|
|
mohr syndrome
|
[NCBI]
|
0.00034389
|
|
|
varadi-papp syndrome
|
[NCBI]
|
0.000324043
|
|
|
PWS
|
[NCBI]
|
0.000235512
|
|
|
JBTS1
|
[NCBI]
|
0.000200942
|
|
|
breath-holding spells
|
[NCBI]
|
0.000190363
|
|
|
AVP
|
[NCBI]
|
0.00015476
|
|
|
ACHE
|
[NCBI]
|
0.000138323
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
0.000128002
|
|
|
CDD
|
[NCBI]
|
0.000101014
|
|
|
respiratory rhythmicity in sleep
|
[NCBI]
|
8.815e-05
|
|
|
methane production
|
[NCBI]
|
8.37881e-05
|
|
|
cleft larynx, posterior
|
[NCBI]
|
8.37881e-05
|
|
|
mitochondrial complex iii deficiency
|
[NCBI]
|
7.47565e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
7.1434e-05
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
7.1434e-05
|
|
|
ECEL1
|
[NCBI]
|
6.81406e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
6.01514e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
5.85122e-05
|
|
|
LAM
|
[NCBI]
|
5.70713e-05
|
|
|
CRH
|
[NCBI]
|
5.70503e-05
|
|
|
RA
|
[NCBI]
|
5.37433e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
5.08487e-05
|
|
|
HOKPP
|
[NCBI]
|
4.62165e-05
|
|
|
MG
|
[NCBI]
|
4.24587e-05
|
|
|
CVS
|
[NCBI]
|
4.00105e-05
|
|
|
SLE
|
[NCBI]
|
3.77139e-05
|
|
|
HYPP
|
[NCBI]
|
3.73049e-05
|
|
|
NALCN
|
[NCBI]
|
3.58108e-05
|
|
|
HHT
|
[NCBI]
|
3.25068e-05
|
|
|
HTR4
|
[NCBI]
|
2.91837e-05
|
|
|
TD1
|
[NCBI]
|
2.81692e-05
|
|
|
SLC6A9
|
[NCBI]
|
2.69968e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.67648e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
2.64981e-05
|
|
|
FCGRT
|
[NCBI]
|
2.61476e-05
|
|
|
POU3F1
|
[NCBI]
|
2.61476e-05
|
|
|
ATOH1
|
[NCBI]
|
2.61476e-05
|
|
|
SIM2
|
[NCBI]
|
2.54055e-05
|
|
|
TFAM
|
[NCBI]
|
2.54055e-05
|
|
|
EPO
|
[NCBI]
|
2.48673e-05
|
|
|
LS
|
[NCBI]
|
2.38291e-05
|
|
|
NPY
|
[NCBI]
|
2.19536e-05
|
|
|
TH
|
[NCBI]
|
2.13399e-05
|
|
|
CPT2
|
[NCBI]
|
1.99286e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.89277e-05
|
|
|
RNASE3
|
[NCBI]
|
1.84064e-05
|
|
|
ACH
|
[NCBI]
|
1.80138e-05
|
|
|
PI
|
[NCBI]
|
1.79955e-05
|
|
|
IRS2
|
[NCBI]
|
1.76921e-05
|
|
|
CRC
|
[NCBI]
|
1.74029e-05
|
|
|
BCHE
|
[NCBI]
|
1.7279e-05
|
|
|
MYH11
|
[NCBI]
|
1.60878e-05
|
|
|
SLC2A2
|
[NCBI]
|
1.40092e-05
|
|
|
CAT
|
[NCBI]
|
1.25845e-05
|
|
|
CPE
|
[NCBI]
|
1.11509e-05
|
|
|
UCP2
|
[NCBI]
|
9.89547e-06
|
|
|
VEGF
|
[NCBI]
|
9.53558e-06
|
|
|
ADCYAP1
|
[NCBI]
|
9.52724e-06
|
|
|
UCP1
|
[NCBI]
|
8.96242e-06
|
|
|
TNF
|
[NCBI]
|
8.49393e-06
|
|
|
SST
|
[NCBI]
|
7.31665e-06
|
|
|
NPPA
|
[NCBI]
|
7.00155e-06
|
|
|
VIP
|
[NCBI]
|
6.90527e-06
|
|
|
MDD
|
[NCBI]
|
6.51085e-06
|
|
|
GDNF
|
[NCBI]
|
6.18094e-06
|
|
|
SOD1
|
[NCBI]
|
5.63497e-06
|
|
|
PNMT
|
[NCBI]
|
5.44342e-06
|
|
|
INS
|
[NCBI]
|
4.71527e-06
|
|
|
SLC6A4
|
[NCBI]
|
4.71527e-06
|
|
|
MB
|
[NCBI]
|
3.38693e-06
|
|
|
SRF
|
[NCBI]
|
3.27356e-06
|
|
|
ALD
|
[NCBI]
|
3.24846e-06
|
|
|
HP
|
[NCBI]
|
3.19118e-06
|
|
|
CYP1A1
|
[NCBI]
|
2.76327e-06
|
|
|
SOD2
|
[NCBI]
|
2.31913e-06
|
|
|
BDNF
|
[NCBI]
|
2.27073e-06
|
|
|
TFPI
|
[NCBI]
|
2.24142e-06
|
|
|
CHAT
|
[NCBI]
|
1.9806e-06
|
|
|
CCK
|
[NCBI]
|
1.89177e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.77853e-06
|
|
|
COMT
|
[NCBI]
|
1.74995e-06
|
|
|
PTHLH
|
[NCBI]
|
1.65022e-06
|
|
|
GFAP
|
[NCBI]
|
1.61958e-06
|
|
|
SLC6A3
|
[NCBI]
|
1.36654e-06
|
|
|
CEACAM5
|
[NCBI]
|
1.14417e-06
|
|
|
HBB
|
[NCBI]
|
9.93903e-07
|
|
|
PRL
|
[NCBI]
|
9.22157e-07
|
|
|
MPO
|
[NCBI]
|
5.74544e-07
|
|
|
PD
|
[NCBI]
|
5.03215e-07
|
|
|
TG
|
[NCBI]
|
4.91348e-07
|
|
|
APOE
|
[NCBI]
|
4.6218e-07
|
|
|
LPL
|
[NCBI]
|
1.25601e-07
|
|
|
CFTR
|
[NCBI]
|
7.53034e-08
|
|